Apply for the At • Home Study
  • Home
  • About
    • Team
    • How it Works
  • In The News
  • Contact Us

ObvioHealth to Conduct a Pioneering Decentralized Clinical Trial on The Mi-Helper Device for Treatment of Migraine

by jennlbpak | Mar 16, 2023 | In the News

NEW YORK, March 16, 2023 /PRNewswire/ — ObvioHealth and Mi-Helper, Inc. announce a partnership to conduct a decentralized clinical trial for a non-invasive neuromodulation device for the treatment of migraines. The randomized controlled trial...
Next Entries »

Stay in Touch

I am interested in keeping up with
Mi-Helper and joining the mailing list

Success!

Subscribe

Mi-Helper At Home Study 

See if you qualify to participate in our at-home study!

Recruiting Now!

Apply Now
Contact Us

Mi-Helper is an Investigational Device and is not approved for use outside of a Clinical Trial Setting.

© 2025 Mi-Helper |  Privacy Policy & Terms & Conditions | Accessibility Statement